Allplex™ Bacterial Vaginosis Assay simultaneously detects 7 bacteria (G. vaginalis, A. vaginae, Megasphaera type 1, BV-associated bacteria 2, Mobiluncus spp., B. fragilis, Lactobacillus spp.) associated with vaginosis. It provides quantitative information of 3 major bacteria (G. vaginalis, A. vaginae, Lactobacillus spp.). Based on Seegene’s proprietary MuDT™ technology, this assay makes it possible to report individual Ct value of multiple bacteria in a single channel. The CE-IVD mark will allow more opportunities for Seegene to market and sell within the European Union.
Dec 15, 2009| Allplex™ Bacterial Vaginosis Assay
Seeplex® Diarrhea-V ACE Detection Detection of diarrhea-causing viruses and bacteria Obtained Medical Device License By Health Canada : Seeplex® Diarrhea-V ACE Detection
Dec 01, 2009| Seeplex® Diarrhea-V ACE Detection
Anyplex™ FluA 3 Real-time SubtypingAnyplex™ FluA 3 Real-time Subtyping enables simultaneous discrimination of 2009 pandemic H1, seasonal influenza A virus (H1) and seasonal influenza A virus (H3) by One-step Multiplex Real-time RT-PCR. Anyplex™ FluA 3 Real-time Subtyping enables simultaneous discrimination of 2009 pandemic H1, seasonal influenza A virus (H1), seasonal influenza A virus (H3) by One-step Multiplex Real-time RT-PCR from nasopharyngeal swabs, nasopharyngeal aspirates, and bronchoalveolar lavage.
Dec 01, 2009| Anyplex™ FluA 3 Real-time Subtyping
Anyplex™ FluA 2 Real-time Subtyping Anyplex™ FluA 2 Real-time Subtyping enables simultaneous discrimination of influenza A virus (H1) and influenza A virus (H3) by One-step Multiplex Real-time RT-PCR. Anyplex™ FluA 2 Real-time Subtyping enables simultaneous discrimination of influenza A virus (H1) and influenza A virus (H3) by One-step Multiplex Real-time RT-PCR from nasopharyngeal swabs, nasopharyngeal aspirates, and bronchoalveolar lavage.
Dec 01, 2009| Anyplex™ FluA 2 Real-time Subtyping
Detection of HSV1 & HSV2Seegene's Seeplex® HSV2 ACE Detection has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.
Nov 27, 2009| Seeplex® HSV2 ACE Detection
Seeplex® CMV ACE Detection Seegene's Seeplex® CMV ACE Detection has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.
Nov 02, 2009| Seeplex® CMV ACE Detection
Detection and identification of influenza A virus and influenza B virusWhile 2009 H1N1 Flu, seasonal influenza A and B have similar symptoms, they should be differentiated because the correct antiviral drug must be prescribed for efficacious treatment. 2009 H1N1 Flu, seasonal influenza A (H3N2), and seasonal influenza B viruses are susceptible to the neuraminidase inhibitor (Tamiflu); in contrast, seasonal influenza A (H1N1) is resistant to this drug. Also, influenza B virus is easier to catch in fall/winter and symptoms are similar to those of influenza A virus. Therefore, it is essential to differentiate between 2009 H1N1 Flu and other seasonal influenza viruses for administration of the appropriate therapy and prevention of drug resistance.
Nov 01, 2009| Seeplex® Influenza A/B OneStep Typing
Anyplex™ FluA/New H1N1 Real-time Detection Anyplex™ FluA/New H1N1 Real-time Detection enables simultaneous detection of 2009 pandemic H1 and influenza A virus. Anyplex™ FluA/New H1N1 Real-time Detection enables simultaneous detection of 2009 pandemic H1 and influenza A virus from nasopharyngeal swabs, nasopharyngeal aspirates, and bronchoalveolar lavage in a single reaction.
Nov 01, 2009| Anyplex™ FluA/New H1N1 Real-Time Detection